White House economic adviser Kevin Hassett, the frontrunner to be the Fed's next chair, told the WSJ CEO Council on Tuesday ...
The CDC's vaccine advisory panel meets Thursday and Friday to discuss recommendations for the hepatitis B vaccine and the ...
A federal vaccine advisory panel could make changes to the childhood vaccine schedule when they meet Friday. A look at what was discussed on day one of the meeting of advisers ...
In a meeting punctuated by conflict and confusion, the independent vaccine advisers to the US Centers for Disease Control and Prevention on Thursday again delayed a vote that could dramatically change ...
Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today, and they could vote on possible changes to the childhood vaccination schedule. Follow here for live updates ...
October meeting with the FDA confirm the agency doesn't see the data collected so far as enough to support an approval filing ...
Some employees are guilty of coffee badging, or even jiggling their mouses to look active while working remotely. But even when they’re being productive on the job, there are a few tasks that could be ...
Mamdani and Trump finally come face-to-face after the president's threats to pull federal funding for New York City. The realities of the drug trade in Latin America call into question part of the ...
Hooters CEO says private equity turned it into a ‘boys club hangout’—Now he’s plotting a family-friendly makeover Prison employees have been terminated after Ghislaine Maxwell’s email messages were ...
Charlie Coyle put up a career-high four assists against the Leafs. Russell LaBounty / Imagn Images COLUMBUS, Ohio — On Wednesday morning in Nationwide Arena, center Charlie Coyle and wingers Cole ...
Copper retreated from the previous session’s record high after US President Donald Trump and his Chinese counterpart Xi Jinping concluded pivotal trade talks. The London Metal Exchange’s benchmark ...
Applied Therapeutics shares lost more than half of their value on Monday after the clinical-stage biopharmaceutical company reported disappointing results from a meeting with the U.S. Food and Drug ...